ImmunityBio, Inc. IBRX

The FDA is despicable. How can it take this long to give Anktiva the green light for all bladder cancer when we all know it works.

So when ImmunityBio submits for lung cancer it will be a 1 plus year review again.

This is all by design to protect Big Pharma and corporate healthcare delivering the IVs and radiation over and over until they kill the patients.

Dare👿🖕👉👿👉👿👉👿die you POS

Remember everything we retail peons know all of Wall Street knows the hedge funds, private equity, mutual funds all the pros know everything we know and more. So SO. The only way to really move the share price of IBRX is with new buyers and that's why we need real MSM coverage. The boycott by them to protect the BP ad revenues is real and why they won't do a story on Dr PSS or ImmunityBio. So there will be not stupid short squeeze fantasy unless you can get CNBC or FoxB to feature ImmunityBio. ZERO CHANCE GET IT...🦶

Wild ride today

Best thing for all of us Trump fully destroys the Iranians in power, arm the civilians to finish the job and use air strikes to support the people's take over. If not that bomb them back to the Stone Ages and let their Muslim Arab friends nations rebuild them.

Craven Moorhead I remember you and your gross childish pathetic immature chosen name Craven Moorhead 🤮

The daily pain continues to test the longs.

Ask yourself where will sales and profits be in 3-5 years and the share price of lower sell my bet way way higher with multiple use approvals and $50-$100 share price

So fucking sick of short talk on this board and the fantastic short squeeze fantasy of morons

I long for a super cycle up way past due with all the clinical trials, possible uses and market. Who should we blame. MSM no question about it the media coverage instead of fair coverage it's a boycott of Dr. PSS and ImmunityBio.

Paul Silberberg your thoughts please